Vistra stock was rising Tuesday after authorities lifted evacuation orders issued because of a fire at a company power plant last week. The utility stock gained 8.8% to $185.83 in afternoon trading, ...

Affirm Holdings has a bright future, but its quarterly report could prove disappointing, Susquehanna Financial Group argued. Analysts James Friedman and Madeleine Zhou downgraded shares of the “buy ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

Today, we're tracking presentations from AbbVie, UCB, WuXi AppTec and several other biopharma firms. Aside from JPM conference coverage, our reporters are making their way around town for one-on ...

What casts more doubt on the 29-year-old's future, however, is the condition of his wrist. The former Wimbledon finalist suffered problems again during the match, bandaging it on one occasion due ...

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

AbbVie (ABBV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...